2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Alphabet Inc. | — | 3,125,312 | Mar 19, 2018 |
| Gv 2016 Gp, L.L.C. | — | 3,125,312 | Mar 19, 2018 |
| Gv 2016 Gp, L.P. | — | 3,125,312 | Mar 19, 2018 |
| Gv 2016, L.P. | — | 3,125,312 | Mar 19, 2018 |
| Rosen Terry J | CEO | 2,554,160 | Feb 27, 2025 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 23, 2026 | Jan 26, 2026 | Markus Richard | Chief Medical Officer | Neutral | 90.0 | +24,000 | 36.56% | ✗ | - |
| Jan 23, 2026 | Jan 26, 2026 | ROSEN TERRY J | CEO | Neutral | 82.5 | +79,000 | 3.66% | ✗ | - |
| Jan 23, 2026 | Jan 26, 2026 | Jaen Juan C. | President | Neutral | 77.5 | +31,000 | 2.44% | ✗ | - |
| Jan 23, 2026 | Jan 26, 2026 | Tang Carolyn C. | General Counsel | Neutral | 90.0 | +24,000 | 19.24% | ✗ | - |
| Jan 23, 2026 | Jan 26, 2026 | Goeltz II Robert C. | CFO | Neutral | 90.0 | +24,000 | 35.33% | ✗ | - |
| Jan 23, 2026 | Jan 26, 2026 | Azoy Alexander | Chief Accounting Officer | Neutral | 90.0 | +21,050 | 113.59% | ✗ | - |
| Jan 23, 2026 | Jan 26, 2026 | Jarrett Jennifer | COO | Neutral | 90.0 | +31,000 | 16.06% | ✗ | - |
| Jan 8, 2026 | Jan 9, 2026 | ROSEN TERRY J | CEO | Neutral | 27.5 | -35,000 | -1.60% | ✗ | - |
| Jan 5, 2026 | Jan 7, 2026 | Jaen Juan C. | President | Sell | 41.3 | -31,823 | -2.45% | ✓ | $681.3K |
| Dec 31, 2025 | Jan 2, 2026 | Goeltz II Robert C. | CFO | Sell | 30.0 | -6,552 | -8.80% | ✓ | $153.2K |
| Dec 30, 2025 | Jan 2, 2026 | ROSEN TERRY J | CEO | Neutral | 52.5 | -2,400 | -0.11% | ✗ | - |
| Dec 16, 2025 | Dec 18, 2025 | Tang Carolyn C. | General Counsel | Sell | 40.0 | -14,468 | -10.39% | ✗ | $318.5K |
| Dec 16, 2025 | Dec 18, 2025 | Markus Richard | Chief Medical Officer | Sell | 42.5 | -9,546 | -12.70% | ✗ | $210.1K |
| Dec 16, 2025 | Dec 18, 2025 | Azoy Alexander | Chief Accounting Officer | Sell | 10.0 | -8,832 | -32.28% | ✓ | $195.4K |
| Dec 16, 2025 | Dec 18, 2025 | Goeltz II Robert C. | CFO | Sell | 40.0 | -12,662 | -14.53% | ✗ | $278.7K |
| Dec 16, 2025 | Dec 18, 2025 | Jarrett Jennifer | COO | Sell | 40.0 | -21,208 | -9.90% | ✗ | $466.9K |
| Dec 16, 2025 | Dec 18, 2025 | Jaen Juan C. | President | Sell | 40.0 | -21,208 | -1.61% | ✗ | $466.9K |
| Dec 16, 2025 | Dec 18, 2025 | ROSEN TERRY J | CEO | Sell | 37.5 | -54,691 | -2.43% | ✗ | $1.2M |
| Dec 4, 2025 | Dec 5, 2025 | Jaen Juan C. | President | Sell | 27.5 | -82,997 | -5.91% | ✓ | $2.1M |
| Nov 26, 2025 | Dec 1, 2025 | Azoy Alexander | Chief Accounting Officer | Sell | 36.3 | -1,900 | -6.49% | ✓ | $49.4K |
| Nov 26, 2025 | Nov 26, 2025 | Goeltz II Robert C. | CFO | Sell | 32.5 | -5,000 | -5.43% | ✓ | $125K |
| Nov 17, 2025 | Nov 19, 2025 | Jaen Juan C. | President | Sell | 32.5 | -50,000 | -3.44% | ✓ | $1M |
| Nov 7, 2025 | Nov 12, 2025 | Jarrett Jennifer | COO | Sell | 17.5 | -50,291 | -19.01% | ✓ | $954.1K |
| Oct 30, 2025 | Nov 3, 2025 | Jaen Juan C. | President | Sell | 48.8 | -4,314 | -0.30% | ✓ | $87.6K |
| Oct 28, 2025 | Oct 30, 2025 | Jaen Juan C. | President | Sell | 27.5 | -96,859 | -6.23% | ✓ | $2M |
| Oct 28, 2025 | Oct 29, 2025 | Goeltz II Robert C. | CFO | Sell | 32.5 | -5,000 | -5.15% | ✓ | $100K |
| Oct 6, 2025 | Oct 8, 2025 | Jarrett Jennifer | COO | Sell | 22.5 | -50,292 | -10.50% | ✓ | $750.4K |
| Sep 29, 2025 | Sep 30, 2025 | Azoy Alexander | Chief Accounting Officer | Sell | 32.5 | -2,831 | -9.38% | ✓ | $36.8K |
| Sep 5, 2025 | Sep 5, 2025 | Azoy Alexander | Chief Accounting Officer | Sell | 41.3 | -1,579 | -4.97% | ✓ | $18.8K |
| Jun 10, 2025 | Jun 12, 2025 | PERLMAN ANDREW J | Director | Neutral | 90.0 | +13,300 | 45.35% | ✗ | - |
| Jun 10, 2025 | Jun 12, 2025 | FALBERG KATHRYN E | Director | Neutral | 85.0 | +13,300 | 8.45% | ✗ | - |
| Jun 10, 2025 | Jun 12, 2025 | Machado Patrick | Director | Neutral | 90.0 | +13,300 | 52.57% | ✗ | - |
| Jun 10, 2025 | Jun 12, 2025 | Ribas Antoni | Director | Neutral | 90.0 | +13,300 | 34.19% | ✗ | - |
| Jun 10, 2025 | Jun 12, 2025 | Lacey David L. | Director | Neutral | 90.0 | +13,300 | 23.07% | ✗ | - |
| Jun 10, 2025 | Jun 12, 2025 | KANEKO YASUNORI | Director | Neutral | 77.5 | +13,300 | 1.42% | ✗ | - |
| Jun 10, 2025 | Jun 12, 2025 | Lambert Nicole | Director | Neutral | 90.0 | +13,300 | 55.42% | ✗ | - |
| Feb 27, 2025 | Feb 27, 2025 | KANEKO YASUNORI | Director | Buy | 82.5 | +20,000 | 2.18% | ✗ | $201.2K |
| Feb 27, 2025 | Feb 27, 2025 | ROSEN TERRY J | CEO | Buy | 72.5 | +19,800 | 0.78% | ✗ | $201.5K |
| Feb 10, 2025 | Feb 11, 2025 | Markus Richard | Chief Medical Officer | Neutral | 90.0 | +75,193 | 100.00% | ✗ | - |
| Feb 11, 2025 | Markus Richard | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 10, 2025 | Berger Dietmar | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 23, 2025 | Jan 27, 2025 | Tang Carolyn C. | General Counsel | Neutral | 90.0 | +37,000 | 36.77% | ✗ | - |
| Jan 23, 2025 | Jan 27, 2025 | ROSEN TERRY J | CEO | Neutral | 85.0 | +165,000 | 6.96% | ✗ | - |
| Jan 23, 2025 | Jan 27, 2025 | Ribas Antoni | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2025 | Jan 27, 2025 | Jarrett Jennifer | COO | Neutral | 90.0 | +50,000 | 30.61% | ✗ | - |
| Jan 23, 2025 | Jan 27, 2025 | Goeltz II Robert C. | CFO | Neutral | 90.0 | +37,000 | 61.53% | ✗ | - |
| Jan 23, 2025 | Jan 27, 2025 | Azoy Alexander | Chief Accounting Officer | Neutral | 90.0 | +17,100 | 130.59% | ✗ | - |
| Jan 23, 2025 | Jan 27, 2025 | Lacey David L. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2025 | Jan 27, 2025 | Jaen Juan C. | President | Neutral | 82.5 | +50,000 | 3.32% | ✗ | - |
| Dec 31, 2024 | Jan 3, 2025 | Goeltz II Robert C. | CFO | Sell | 32.5 | -3,594 | -5.64% | ✓ | $53.9K |
| Dec 19, 2024 | Dec 20, 2024 | Azoy Alexander | Chief Accounting Officer | Sell | 23.8 | -3,007 | -18.68% | ✓ | $45.6K |
| Dec 15, 2024 | Dec 17, 2024 | Jarrett Jennifer | COO | Sell | 40.0 | -27,501 | -14.41% | ✗ | $442.2K |
| Dec 15, 2024 | Dec 17, 2024 | Tang Carolyn C. | General Counsel | Sell | 42.5 | -11,339 | -10.13% | ✗ | $182.3K |
| Dec 15, 2024 | Dec 17, 2024 | ROSEN TERRY J | CEO | Sell | 40.0 | -37,882 | -1.57% | ✗ | $609.1K |
| Dec 15, 2024 | Dec 17, 2024 | Nuyten Dimitry SA | Chief Medical Officer | Sell | 42.5 | -7,856 | -8.24% | ✗ | $126.3K |
| Dec 15, 2024 | Dec 17, 2024 | Goeltz II Robert C. | CFO | Sell | 42.5 | -10,099 | -13.68% | ✗ | $162.4K |
| Dec 15, 2024 | Dec 17, 2024 | Azoy Alexander | Chief Accounting Officer | Sell | 46.3 | -2,969 | -15.57% | ✗ | $47.7K |
| Dec 15, 2024 | Dec 17, 2024 | Jaen Juan C. | President | Sell | 40.0 | -17,286 | -1.14% | ✗ | $278K |
| Dec 2, 2024 | Dec 4, 2024 | Azoy Alexander | Chief Accounting Officer | Sell | 50.0 | -201 | -1.04% | ✓ | $3.1K |
| Sep 15, 2024 | Sep 17, 2024 | Jarrett Jennifer | COO | Sell | 42.5 | -12,670 | -6.24% | ✗ | $227.4K |
| Sep 15, 2024 | Sep 17, 2024 | Nuyten Dimitry SA | Chief Medical Officer | Sell | 42.5 | -5,385 | -5.37% | ✗ | $96.7K |
| Aug 13, 2024 | Aug 15, 2024 | Azoy Alexander | Chief Accounting Officer | Sell | 36.3 | -1,357 | -6.64% | ✓ | $20.3K |
| Jun 15, 2024 | Jun 18, 2024 | ROSEN TERRY J | CEO | Sell | 47.5 | -12,670 | -0.32% | ✗ | $215K |
| Jun 15, 2024 | Jun 18, 2024 | Jaen Juan C. | President | Sell | 47.5 | -6,969 | -0.46% | ✗ | $118.3K |
| Jun 15, 2024 | Jun 18, 2024 | Jarrett Jennifer | COO | Sell | 42.5 | -12,670 | -5.87% | ✗ | $215K |
| Jun 15, 2024 | Jun 18, 2024 | Tang Carolyn C. | General Counsel | Sell | 42.5 | -4,182 | -3.62% | ✗ | $71K |
| Jun 6, 2024 | Jun 7, 2024 | KANEKO YASUNORI | Director | Neutral | 67.5 | +8,400 | 0.92% | ✗ | - |
| Jun 6, 2024 | Jun 7, 2024 | Lacey David L. | Director | Neutral | 90.0 | +8,400 | 17.06% | ✗ | - |
| Jun 6, 2024 | Jun 7, 2024 | FALBERG KATHRYN E | Director | Neutral | 85.0 | +8,400 | 5.64% | ✗ | - |
| Jun 6, 2024 | Jun 7, 2024 | Machado Patrick | Director | Neutral | 90.0 | +8,400 | 49.70% | ✗ | - |
| Jun 6, 2024 | Jun 7, 2024 | PERLMAN ANDREW J | Director | Neutral | 90.0 | +8,400 | 40.14% | ✗ | - |
| Jun 6, 2024 | Jun 7, 2024 | Ribas Antoni | Director | Neutral | 90.0 | +8,400 | 27.54% | ✗ | - |
| Jun 6, 2024 | Jun 7, 2024 | Lambert Nicole | Director | Neutral | 90.0 | +8,400 | 53.85% | ✗ | - |
| Mar 27, 2024 | Mar 29, 2024 | Jarrett Jennifer | COO | Sell | 32.5 | -11,551 | -5.09% | ✓ | $202.7K |
| Mar 18, 2024 | Mar 20, 2024 | Jarrett Jennifer | COO | Sell | 42.5 | -13,449 | -5.60% | ✗ | $240.9K |
| Feb 26, 2024 | Feb 28, 2024 | Jarrett Jennifer | COO | Sell | 15.0 | -58,625 | -19.62% | ✓ | $1.2M |
| Feb 26, 2024 | Feb 28, 2024 | Jaen Juan C. | President | Sell | 42.5 | -27,032 | -1.74% | ✓ | $543.2K |
| Jan 23, 2024 | Feb 23, 2024 | Goeltz II Robert C. | CFO | Neutral | 90.0 | +22,000 | 42.45% | ✗ | - |
| Feb 7, 2024 | Mercier Johanna | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 23, 2024 | Jan 25, 2024 | Goeltz II Robert C. | CFO | Neutral | 90.0 | +21,300 | 41.10% | ✗ | - |
| Jan 23, 2024 | Jan 25, 2024 | Jaen Juan C. | President | Neutral | 90.0 | +40,000 | 13.27% | ✗ | - |
| Jan 23, 2024 | Jan 25, 2024 | Azoy Alexander | Chief Accounting Officer | Neutral | 90.0 | +8,850 | 86.59% | ✗ | - |
| Jan 23, 2024 | Jan 25, 2024 | Tang Carolyn C. | General Counsel | Neutral | 90.0 | +26,700 | 30.38% | ✗ | - |
| Jan 23, 2024 | Jan 25, 2024 | ROSEN TERRY J | CEO | Neutral | 82.5 | +100,000 | 2.59% | ✗ | - |
| Jan 23, 2024 | Jan 25, 2024 | Jarrett Jennifer | COO | Neutral | 90.0 | +40,000 | 15.45% | ✗ | - |
| Jan 23, 2024 | Jan 25, 2024 | Nuyten Dimitry SA | Chief Medical Officer | Neutral | 90.0 | +28,000 | 39.33% | ✗ | - |
| Jan 2, 2024 | Jan 4, 2024 | Goeltz II Robert C. | CFO | Sell | 41.3 | -2,004 | -3.72% | ✓ | $40.1K |
| Jan 2, 2024 | Jan 4, 2024 | Jaen Juan C. | President | Sell | 48.8 | -6,975 | -0.46% | ✓ | $140.1K |
| Dec 29, 2023 | Jan 2, 2024 | ROSEN TERRY J | CEO | Neutral | 47.5 | +448 | 0.01% | ✗ | - |
| Dec 22, 2023 | Dec 26, 2023 | Jarrett Jennifer | COO | Sell | 26.3 | -21,521 | -7.68% | ✓ | $382.2K |
| Dec 20, 2023 | Dec 22, 2023 | Azoy Alexander | Chief Accounting Officer | Sell | 52.5 | -68 | -0.66% | ✓ | $1.2K |
| Dec 18, 2023 | Dec 20, 2023 | Tang Carolyn C. | General Counsel | Sell | 42.5 | -8,067 | -8.41% | ✗ | $144.5K |
| Dec 18, 2023 | Dec 20, 2023 | Nuyten Dimitry SA | Chief Medical Officer | Sell | 42.5 | -3,047 | -4.10% | ✗ | $54.6K |
| Dec 18, 2023 | Dec 20, 2023 | Azoy Alexander | Chief Accounting Officer | Sell | 46.3 | -1,308 | -11.28% | ✗ | $23.4K |
| Dec 18, 2023 | Dec 20, 2023 | Goeltz II Robert C. | CFO | Sell | 42.5 | -5,557 | -9.36% | ✗ | $99.6K |
| Dec 18, 2023 | Dec 20, 2023 | Jarrett Jennifer | COO | Sell | 40.0 | -22,742 | -7.50% | ✗ | $407.5K |
| Dec 18, 2023 | Dec 20, 2023 | Jaen Juan C. | President | Sell | 45.0 | -12,387 | -0.81% | ✗ | $221.9K |
| Dec 18, 2023 | Dec 20, 2023 | ROSEN TERRY J | CEO | Sell | 42.5 | -27,705 | -0.71% | ✗ | $496.4K |
| Dec 1, 2023 | Dec 5, 2023 | Azoy Alexander | Chief Accounting Officer | Sell | 46.3 | -282 | -2.37% | ✓ | $4.2K |
| Sep 22, 2023 | Sep 26, 2023 | Jarrett Jennifer | COO | Sell | 30.0 | -21,369 | -6.59% | ✓ | $427.2K |